NCT02271581View on ClinicalTrials.gov

Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 19, 2019

Study Completion Date

April 19, 2019

Conditions
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Trial Locations (1)

27834

Leo Jenkins Cancer Center, Greenville

All Listed Sponsors
lead

Leo W. Jenkins Cancer Center

OTHER

NCT02271581 - Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer | Biotech Hunter | Biotech Hunter